Skip to content

Integra LifeSciences IART Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$4.62M-171%-$1.7M+68.5%-$5.4M+98.9%-$484.07M-1,814%-$25.29M
$38.43M0.0%$38.43M-0.2%$38.52M+2.2%$37.69M+1.4%$37.19M-1.1%
$5.17M-11.5%$5.84M+4.6%$5.58M+5.4%$5.3M+183%$1.87M-73.9%
$9.8M-17.0%$11.82M-71.1%$40.91M+359%$8.92M+179%-$11.26M-122%
$14.85M-13.7%$17.21M+13.6%$15.16M-24.8%$20.15M-30.3%$28.92M-2.3%
-$14.85M+57.5%-$34.91M-124%-$15.59M+28.0%-$21.65M+39.7%-$35.92M-745%
$8.3M-65.9%$24.34M$35.38M
$1.76M-$21.19M-191%-$7.27M
-$5.05M+6.5%-$5.4M-$11.23M+72.1%-$40.18M-290%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Integra LifeSciences generate?
Integra LifeSciences (IART) generated $71.4M in operating cash flow over the trailing twelve months.
What is Integra LifeSciences's free cash flow?
After $67.4M of capital expenditures, Integra LifeSciences's free cash flow was -$61.8M over the trailing twelve months, down 193.2% year over year.
Where does Integra LifeSciences's cash flow data come from?
Every line is extracted from Integra LifeSciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.